335564 <common-name>4-[4-[[(2s,4r)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1,4-thiazinane 1-oxide</common-name> <description>4-[4-[[(2s,4r)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1,4-thiazinane 1-oxide is a chemical compound with the formula C23H24Cl2N4O4S. With an average molecular weight of 523.40 g/mol, 4-[4-[[(2s,4r)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1,4-thiazinane 1-oxide is a heavy molecule.</description> <cas>103661-10-5</cas> <pubchem-id>44153651</pubchem-id> <chemical-formula>C23H24Cl2N4O4S</chemical-formula> <weight>523.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T17:45:37Z</created-at> <updated-at type="dateTime">2026-08-30T17:45:37Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CS(=O)CCN1C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl</moldb-smiles> <moldb-formula>C23H24Cl2N4O4S</moldb-formula> <moldb-inchi>InChI=1S/C23H24Cl2N4O4S/c24-17-1-6-21(22(25)11-17)23(14-29-16-26-15-27-29)32-13-20(33-23)12-31-19-4-2-18(3-5-19)28-7-9-34(30)10-8-28/h1-6,11,15-16,20H,7-10,12-14H2/t20-,23-/m1/s1</moldb-inchi> <moldb-inchikey>UCIROMKTXYHXEI-NFBKMPQASA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">522.0895318</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM331457</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4-[4-[[(2s,4r)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1,4-thiazinane 1-oxide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Thiazinanes</klass> <subklass>Thiomorpholines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0286035</sync-id> <structure-inchikey>UCIROMKTXYHXEI-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>41001000080880002000000000001000400000000000080004000000000000000000000200000000002002000000100000000000000000000400000000002000800400000000000000000000030800000010100000200000014000000000000000080000001000002100000000000020900000000002000000000508000000008020000000800000000800000000000000000400000000000000000000000000000008000000000080100040001000000080000008000000000000000000000000000001000000000000000000010000400000000000200000000020000000040000000020244000000000010008100040000080000000000040000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAgIGAGAAAAAC AhAAIAAAAAQIACgAAAADAgYAYAAAAAICBgBgAAAAAgIHACgAAAADAwZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEIACgAAAADAgYAYAAAAAICBgBgAAAAAwEGAGAAAAACAggAIAAAAAIGACAA AAAECAAgAAAAAgYAYAAAAAICB0AoAAAAAwMGQGgAAAADAwEHQCgAAAADAwZA aAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBEQAgAAAAAREAIAAAAAELAAEAAQIAAgMI AgIEAAQFAAUGAAYHIAcIaAwICWgMCQpoDAoLaAwLDGgMCg0gDQ4ADg8ADxAA EBEAERIAEhMAEhQAFBUAFRZoDBYXaAwXGGgMGBloDBIaABobaAwbHGgMHB1o DB0eaAweH2gMHSAAGyEABgAADAdoDBMPABkVaAwfGmgMQgUAAAAGAAYFBAIB BggJCgsMBwUQDxMSEQUWFRkYFwYbHB0eHxoXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:37:15Z</structure-indexed-at> </compound>